MS-based methods for identifying post-translational modification gradually took over other proteomic approaches because of its sensitivity of detection, low run time and reduced biochemical biasness (this is in reference to specific dyes used to stain specific modifications). The use of mass spectrometry based PTM analysis goes way back to the time when scientists characterized the spectrum of hemoglobin from sickle cell anemia. Sickle cell anemia results from a change in one nucleotide of a codon resulting in the change in one amino acid, from glutamic acid to valine. This change in the hemoglobin is evident not only on the phenotype but also on the mass spectrum as well. The fragmentation pattern of both normal and sickle cell hemoglobin are the same. However, one of the ion peaks shifts showed change in mass of 30 Da in case of sickle cell anemia.
Every post-translational modification adds a specific mass to the protein, depending on the number of modifications. For example, a single phosphorylation in the protein would increase the overall protein mass by a magnitude of 80 Da. Identifying the amount of change in the spectrum shift is thus a direct measure of the post-translational modification, in terms of both the number of modifications as well as the site of modification (using tandem MS/MS splitting and sequence determination). However, like every other techniques, MS based approach also faces several limitations, which would be discussed. |